NIH Weekly Funding Opportunities and Policy Notices

Clarification: Fixed Amount Award Definition and Implementation for Clinical Trials
Thursday, September 6, 2018 - 7:49am
Notice NOT-OD-18-222 from the NIH Guide for Grants and Contracts
Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
Wednesday, September 5, 2018 - 9:29am
Funding Opportunity PAR-18-911 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites P20 planning grant applications for developing collaborative partnership between institutions serving underserved health disparity populations and underrepresented students (ISUPS) and NCI- designated Cancer Centers (or Cancer Centers with highly integrated cancer research programs). This FOA is designed to facilitate the planning and execution of focused collaborations in cancer-related research, research experience, and research education. A major goal of the NCI P20 partnership programs is to provide support for investigators at ISUPS and Cancer Centers to conduct cancer research pilot projects and cancer research education program. The purpose of the pilot projects and education program is to allow awardees to obtain preliminary data that will lead to competitive grant applications for funding by the NIH/NCI and/or other Federal/Non-Federal agencies.
Request for Information (RFI): Soliciting Input for future research at the National Heart, Lung, and Blood Institute on Factor VIII (FVIII) immunogenicity and FVIII inhibitor prevention/eradication in patients with Hemophilia A
Wednesday, September 5, 2018 - 8:50am
Notice NOT-HL-18-652 from the NIH Guide for Grants and Contracts
Notice of Extension of the Expiration Date for RFA-MH-18-700 "Clinical Trials to Test the Effectiveness of Treatment, Preventive and Services Interventions (Collaborative R01 Clinical Trial Required)"
Wednesday, September 5, 2018 - 7:23am
Notice NOT-MH-18-050 from the NIH Guide for Grants and Contracts
Notice of Extension of the Expiration Date for RFA-MH-18-701 "Clinical Trials to Test the Effectiveness of Treatment, Preventive and Services Interventions (R01 Clinical Trial Required)"
Wednesday, September 5, 2018 - 7:16am
Notice NOT-MH-18-049 from the NIH Guide for Grants and Contracts
Notice of Extension of the Expiration Date for RFA-MH-18-707 "Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)"
Wednesday, September 5, 2018 - 7:08am
Notice NOT-MH-18-048 from the NIH Guide for Grants and Contracts
Notice of Added Research Goals for RFA-DA-19-005 "Science-Based Quality Measurement and Management Development for Opioid Use Disorder Treatment (R61/R33 Clinical Trial Required)"
Tuesday, September 4, 2018 - 8:11am
Notice NOT-DA-18-037 from the NIH Guide for Grants and Contracts
Notice of Correction of PA-18-871, "BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 Clinical Trial Not Allowed) "
Tuesday, September 4, 2018 - 12:02am
Notice NOT-MH-18-051 from the NIH Guide for Grants and Contracts
Notice of Changes to NICHD Acceptance of Diversity and Re-Entry Supplement Applications
Monday, September 3, 2018 - 11:50pm
Notice NOT-HD-18-018 from the NIH Guide for Grants and Contracts
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Justice Community Opioid Innovation Network Coordination and Translation Center
Monday, September 3, 2018 - 11:33pm
Notice NOT-DA-18-035 from the NIH Guide for Grants and Contracts
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Justice Community Opioid Innovation Network Advanced Analytics and Methodology Center
Monday, September 3, 2018 - 11:28pm
Notice NOT-DA-18-036 from the NIH Guide for Grants and Contracts
Additional Awards Eligible for PA-18-906 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)
Monday, September 3, 2018 - 11:24pm
Notice NOT-OD-18-226 from the NIH Guide for Grants and Contracts
Notice of Pre-Application Webinar for the NIH Common Fund Acute to Chronic Pain Signatures Program
Monday, September 3, 2018 - 11:16pm
Notice NOT-RM-18-021 from the NIH Guide for Grants and Contracts
Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01) (Clinical Trial Required)
Friday, August 31, 2018 - 10:44am
Funding Opportunity PAR-18-910 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications that propose testing new therapeutic uses for experimental drugs or biologics (Assets) across a broad range of human diseases in adult and pediatric populations. This innovative program allows investigators to propose new therapeutic uses for Assets from pharmaceutical company partners. Strong applications will include scientific evidence that modulation of an Assets target will have a positive impact on the disease/condition.
Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 Clinical Trials Not Allowed)
Friday, August 31, 2018 - 10:44am
Funding Opportunity PAR-18-909 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits pre-applications for projects that test new therapeutic uses for experimental drugs or biologics (Assets) across a broad range of human diseases in adult and pediatric populations. This innovative program allows investigators to propose new therapeutic uses for Assets from pharmaceutical company partners. Strong applications will include scientific evidence that modulation of an Assets target will have a positive impact on the disease/condition.
Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional)
Friday, August 31, 2018 - 10:01am
Funding Opportunity RFA-ES-18-007 from the NIH Guide for Grants and Contracts. The purpose of the updated ViCTER program is to use the R01 mechanism to foster and promote early-stage transdisciplinary collaborations and/or translational research efforts among fundamental (technology and mechanism oriented), clinical (patient-oriented) and population-based researchers in the environmental health field. The newly established collaborative teams will come together in common interest to investigate potential linkages between human health and one or more environmental stressor(s). The ViCTER program is intended to support innovative high-risk, high-reward cross-disciplinary and/or translational research projects that are more difficult to achieve in a typical R01 application. Collaboration among investigators at different institutions through a virtual consortium arrangement are encouraged.
Notice of Pre-Application Information Webinar and Frequently Asked Questions (FAQs) for NIH and USDA Prospective Applicants to PAR-17-482 Comparative Genomics Research Program (R01-Clinical Trial Not Allowed)"
Friday, August 31, 2018 - 9:39am
Notice NOT-HG-18-015 from the NIH Guide for Grants and Contracts
Notice of Extension of the Expiration Date for RFA-MH-18-706 "Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required)"
Friday, August 31, 2018 - 9:33am
Notice NOT-MH-18-047 from the NIH Guide for Grants and Contracts
Notice of Extension of the Expiration Date for RFA-MH-18-705 "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33-Clinical Trial Required)
Friday, August 31, 2018 - 9:26am
Notice NOT-MH-18-046 from the NIH Guide for Grants and Contracts
Notice of Extension of the Expiration Date for RFA-MH-18-704 "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33-Clinical Trial Required)"
Friday, August 31, 2018 - 9:17am
Notice NOT-MH-18-045 from the NIH Guide for Grants and Contracts

Pages